FindTrial
Sign In

Inositol treatment for polycystic ovary syndrome (PCOS): Systematic review and meta-analysis

Inositol treatment for polycystic ovary syndrome (PCOS): Systematic review and meta-analysis - Inositol treatment for PCOS

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000025843
Enrollment
100
Registered
2017-02-01
Start date
2017-01-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

None listed

Sponsors

Yokohama University of Pharmacy
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All randomized controlled trial comparing inositol with placebo intake in PCOS are included in this study.

Exclusion criteria

Exclusion criteria: We exclude studies that is not report our primary and secondary outcomes. We also exclude studies that did not set appropriate control group, is review article and is not clinical study.

Design outcomes

Primary

MeasureTime frame
Parameters of glucose metabolism Ovarian function—

Secondary

MeasureTime frame
Serum sex hormone—

Countries

Japan

Contacts

Public ContactKohsuke Hayamizu

Yokohama University of Pharmacy Laboratory of Food Chemistry

k.hayamizu@hamayaku.ac.jp045-859-1300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026